S. 2345In Committee
Short on Competition Act
Require the FDA to temporarily authorize imports of certain prescription drugs in shortage or marginally competitive markets, subject to eligibility, timing, and safety rules
Plain-English overview
What this bill does
Require the FDA to temporarily authorize imports of certain prescription drugs in shortage or marginally competitive markets, subject to eligibility, timing, and safety rules
Key points
- Require temporary drug import authorization
- Limit import authority duration
- Allow FDA safety denials
- Treat marginal markets as shortages
Current status
Where it stands
Status
In Committee
Latest action
2025-07-17 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related context
Topics and policy areas
undefinedHealth